{"abstract": "So-called specialty drugs for diseases like rheumatoid arthritis have a narrow use and high costs, leaving the most vulnerable patients with huge bills.", "web_url": "https://www.nytimes.com/2012/04/13/health/states-seek-to-curb-exorbitant-drug-costs-incurred-by-patients.html", "snippet": "So-called specialty drugs for diseases like rheumatoid arthritis have a narrow use and high costs, leaving the most vulnerable patients with huge bills.", "lead_paragraph": "The hemophilia drug that saves 7-year-old William Addison from uncontrolled bleeding costs $100,000 a year. His family\u2019s insurance pays virtually all of it. ", "print_section": "A", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/04/12/business/copay/copay-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/04/12/business/copay/copay-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/04/12/business/copay/copay-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/04/12/business/copay/copay-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/04/12/business/copay/copay-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "States Seek Curb on Patient Bills for Costly Drugs", "kicker": null, "content_kicker": null, "print_headline": "States Seek Curb On Patient Bills For Costly Drugs", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Reform and Reorganization", "rank": 3, "major": "N"}, {"name": "subject", "value": "Health Insurance and Managed Care", "rank": 4, "major": "N"}, {"name": "subject", "value": "States (US)", "rank": 5, "major": "N"}, {"name": "subject", "value": "Law and Legislation", "rank": 6, "major": "N"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "rank": 7, "major": "N"}], "pub_date": "2012-04-12T21:15:04+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/18bd792e-7619-5099-bea1-22fdb5118c34", "word_count": 1264, "uri": "nyt://article/18bd792e-7619-5099-bea1-22fdb5118c34"}